ASTRAZENECA
AstraZeneca CEO Pascal Soriot Says Their Oxford COVID-19 Vaccine Likely To Be Up To 95% Effective
Oxford COVID-19 Vaccine's Efficacy Rate Will be 'Around 95%', Claims AstraZeneca CEO Ahead of Likely Rollout in UK and India
COVID-19 Vaccine Trials Update: UK's AstraZeneca To Test Its Vaccine in Combination With Russia's Sputnik V
Oxford COVID-19 Vaccine: SII Responds To Chennai Man's Rs 5 Crore Compensation Notice, Says No Relation Of Medical Condition With Vaccine Trial
North Korean Hackers Tried to Break-In To COVID-19 Vaccine Developer AstraZeneca's System, Says Report
AstraZeneca Signs MoU with Indian Diabetes Research Society to Empower One Crore Indian Diabetic Patients by 2023
Oxford COVID-19 Vaccine ‘70% Effective’, Serum Institute Chief Adar Poonawalla Says India Could Give Nod By Year-End
Google Trends